Cargando…
Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study
BACKGROUND: Dry eye disease (DED) affects more than 14% of the elderly population causing decrease of quality of life, high costs and vision impairment. Current treatments for DED aim at lubricating and controlling inflammation of the ocular surface. Development of novel therapies targeting differen...
Autores principales: | Sacchetti, Marta, Lambiase, Alessandro, Schmidl, Doreen, Schmetterer, Leopold, Ferrari, Mauro, Mantelli, Flavio, Allegretti, Marcello, Garhoefer, Gerhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922013/ https://www.ncbi.nlm.nih.gov/pubmed/30944103 http://dx.doi.org/10.1136/bjophthalmol-2018-312470 |
Ejemplares similares
-
Safety and Pharmacokinetics of Escalating Doses of Human Recombinant Nerve Growth Factor Eye Drops in a Double-Masked, Randomized Clinical Trial
por: Ferrari, Mauro P., et al.
Publicado: (2013) -
Autoimmune Diseases and the Anterior Segment of the Eye
por: Sacchetti, Marta, et al.
Publicado: (2018) -
Rare Diseases of the Anterior Segment of the Eye: Update on Diagnosis and Management
por: Lambiase, Alessandro, et al.
Publicado: (2015) -
The Association between Tear Film Thickness as Measured with OCT and Symptoms and Signs of Dry Eye Disease: A Pooled Analysis of 6 Clinical Trials
por: Garhöfer, Gerhard, et al.
Publicado: (2020) -
Effect of Hyaluronic Acid/Trehalose in Two Different Formulations on Signs and Symptoms in Patients with Moderate to Severe Dry Eye Disease
por: Fondi, Klemens, et al.
Publicado: (2018)